{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:36:26Z","timestamp":1787866586351,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["81801465"],"award-info":[{"award-number":["81801465"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The age-specific definition of low anti-m\u00fcllerian hormone (AMH) is lacking. This study aims to define an age-specific reference for low AMH and to evaluate the associated outcome in women undergoing IVF treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was performed in women receiving IVF treatment at the Shenzhen maternity and child healthcare hospital between September 2016 and September 2018. We excluded cases without AMH concentration. Polynomial least-squares regression was used to estimate the age-specific reference ranges for AMH after log-transformed. The age-specific 10<jats:sup>th<\/jats:sup> centile was defined as the threshold of low AMH concentration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 909 patients were analyzed in this study. The age-specific reference ranges for AMH were established using linear regression model and resulted in an age-specific equation for mean: mean of LnAMH\u2009=\u2009(\u2212\u20090.085\u2009\u00d7\u2009age)\u2009+\u20093.722 (ng\/ml, in unit). Women with AMH level higher than 10<jats:sup>th<\/jats:sup> centile had favorable outcomes in ovarian stimulation compared to those with low AMH level. In patients younger than 35\u2009years, the rates of clinical pregnancy per transfer and ongoing pregnancy per transfer in the subgroup with AMH level higher than 10<jats:sup>th<\/jats:sup> centile were significantly higher than that in the subgroup of low AMH level, 57% versus 31.3% <jats:italic>p<\/jats:italic>\u00a0=\u20090.003 and 51.9% versus 21.9% <jats:italic>p<\/jats:italic>\u00a0=\u20090.001, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Women with AMH lower than age-specific 10<jats:sup>th<\/jats:sup> centile had significantly unfavorable outcomes after IVF treatment. The age-specific 10<jats:sup>th<\/jats:sup> centile of AMH concentration may be useful to predict the outcome of IVF treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-03649-0","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T17:03:04Z","timestamp":1614963784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment"],"prefix":"10.1186","volume":"21","author":[{"given":"Depeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"issue":"5","key":"3649_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688\u2013701.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3649_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370\u201385.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"3649_CR3","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.fertnstert.2015.08.027","volume":"104","author":"C Gnoth","year":"2015","unstructured":"Gnoth C, Roos J, Broomhead D, Schiffner J, Godehardt E, Freundl G, Johnson S. Antimullerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day. Fertil Steril. 2015;104(6):1535\u20131543.e1531\u20131534.","journal-title":"Fertil Steril"},{"issue":"1","key":"3649_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","volume":"19","author":"SL Broer","year":"2013","unstructured":"Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, Eijkemans MJ, Mol BW, Broekmans FJ. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19(1):26\u201336.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"3649_CR5","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1093\/humrep\/dei203","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, Gal M, Zylber-Haran E, Margalioth EJ. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod (Oxford, England). 2005;20(11):3178\u201383.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"9","key":"3649_CR6","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. Hum Reprod (Oxford, England). 2007;22(9):2414\u201321.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"3","key":"3649_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2012-3676","volume":"98","author":"T Brodin","year":"2013","unstructured":"Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98(3):1107\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3649_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119\u2013130.e113.","journal-title":"Fertil Steril"},{"key":"3649_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","volume":"225","author":"SSE Alson","year":"2018","unstructured":"Alson SSE, Bungum LJ, Giwercman A, Henic E. Anti-mullerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-mullerian hormone is modest. Eur J Obstet Gynecol Reprod Biol. 2018;225:199\u2013204.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"3649_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","volume":"87","author":"JM Smeenk","year":"2007","unstructured":"Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD. Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2007;87(1):223\u20136.","journal-title":"Fertil Steril"},{"issue":"2","key":"3649_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","volume":"109","author":"R Tal","year":"2018","unstructured":"Tal R, Seifer DB, Wantman E, Baker V, Tal O. Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2018;109(2):258\u201365.","journal-title":"Fertil Steril"},{"issue":"4","key":"3649_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmu003","volume":"20","author":"S Iliodromiti","year":"2014","unstructured":"Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20(4):560\u201370.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"3649_CR13","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1210\/jc.2010-1207","volume":"95","author":"L Aksglaede","year":"2010","unstructured":"Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, et al. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010;95(12):5357\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3649_CR14","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2012-1440","volume":"97","author":"S Lie Fong","year":"2012","unstructured":"Lie Fong S, Visser JA, Welt CK, de Rijke YB, Eijkemans MJ, Broekmans FJ, Roes EM, Peters WH, Hokken-Koelega AC, Fauser BC, et al. Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012;97(12):4650\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3649_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","volume":"101","author":"JM Franasiak","year":"2014","unstructured":"Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT Jr. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656\u2013663.e651.","journal-title":"Fertil Steril"},{"issue":"12","key":"3649_CR16","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","volume":"32","author":"J Cohen","year":"2015","unstructured":"Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions. J Assist Reprod Genet. 2015;32(12):1709\u201312.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3649_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"ZJ Chen","year":"2016","unstructured":"Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"3649_CR18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1515\/cclm-2018-0371","volume":"57","author":"J Jing","year":"2018","unstructured":"Jing J, Xia F, Ding Z, Chen L, Shao Y, Ge YF, Pan P, Tian T, Lan XP, Yao B. A single-center performance evaluation of the fully automated iFlash anti-Mullerian hormone immunoassay. Clin Chem Lab Med. 2018;57(2):e19\u201322.","journal-title":"Clin Chem Lab Med"},{"key":"3649_CR19","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion. Fertil Steril. 2013;99(1):44\u20136.","DOI":"10.1016\/j.fertnstert.2012.09.038"},{"key":"3649_CR20","doi-asserted-by":"crossref","unstructured":"Zhao DP, Li XM. Meeting Abstracts from the 2019 IFFS Shanghai World Congress. 2019;4(1):e30 PS203.","DOI":"10.1097\/GRH.0000000000000030"},{"issue":"26","key":"3649_CR21","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1110238","volume":"366","author":"B Luke","year":"2012","unstructured":"Luke B, Brown MB, Wantman E, Lederman A, Gibbons W, Schattman GL, Lobo RA, Leach RE, Stern JE. Cumulative birth rates with linked assisted reproductive technology cycles. N Engl J Med. 2012;366(26):2483\u201391.","journal-title":"N Engl J Med"},{"issue":"1","key":"3649_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/humrep\/deu266","volume":"30","author":"O Hamdine","year":"2015","unstructured":"Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, Broekmans FJ. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-M\u00fcllerian hormone. Hum Reprod (Oxford, England). 2015;30(1):170\u20138.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"1","key":"3649_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12958-019-0498-3","volume":"17","author":"B Zhang","year":"2019","unstructured":"Zhang B, Meng Y, Jiang X, Liu C, Zhang H, Cui L, Chen ZJ. IVF outcomes of women with discrepancies between age and serum anti-M\u00fcllerian hormone levels. Reprod Biol Endocrinol. 2019;17(1):58.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"3649_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","volume":"14","author":"K Lukaszuk","year":"2014","unstructured":"Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E. Anti-Mullerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol. 2014;14(3):176\u201381.","journal-title":"Reprod Biol"},{"issue":"4","key":"3649_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","volume":"104","author":"O Hamdine","year":"2015","unstructured":"Hamdine O, Eijkemans MJC, Lentjes EGW, Torrance HL, Macklon NS, Fauser B, Broekmans FJ. Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril. 2015;104(4):891\u2013898.e892.","journal-title":"Fertil Steril"},{"issue":"1","key":"3649_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12905-019-0752-z","volume":"19","author":"T Segawa","year":"2019","unstructured":"Segawa T, Omi K, Watanabe Y, Sone Y, Handa M, Kuroda M, Miyauchi O, Osada H, Teramoto S. Age-specific values of access anti-Mullerian hormone immunoassay carried out on Japanese patients with infertility: a retrospective large-scale study. BMC Womens Health. 2019;19(1):57.","journal-title":"BMC Womens Health"},{"issue":"6","key":"3649_CR27","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.fertnstert.2014.02.046","volume":"101","author":"HI Su","year":"2014","unstructured":"Su HI, Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk FZ. Comparability of antim\u00fcllerian hormone levels among commercially available immunoassays. Fertil Steril. 2014;101(6):1766\u20131772.e1761.","journal-title":"Fertil Steril"},{"issue":"4","key":"3649_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.rbmo.2011.06.011","volume":"23","author":"SM Nelson","year":"2011","unstructured":"Nelson SM, La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod BioMed Online. 2011;23(4):411\u201320.","journal-title":"Reprod BioMed Online"},{"issue":"5","key":"3649_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2018.12.041","volume":"38","author":"MH Jacobs","year":"2019","unstructured":"Jacobs MH, Reuter LM, Baker VL, Craig LB, Sakkas D, Surrey E, Doody KJ, Jungheim ES, Bayrak AB, Hund M, et al. A multicentre evaluation of the Elecsys(\u00ae) anti-M\u00fcllerian hormone immunoassay for prediction of antral follicle count. Reprod BioMed Online. 2019;38(5):845\u201352.","journal-title":"Reprod BioMed Online"},{"issue":"2","key":"3649_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0004563220902171","volume":"57","author":"CY Yue","year":"2020","unstructured":"Yue CY, Wu Y, Duan CH, Wei J, Zhang D, Luo XH, Zhang QL, Ying CM. Performance evaluation of a fully automated anti-M\u00fcllerian hormone immunoassay and multicentre study on the establishment of reference range in adult women. Ann Clin Biochem. 2020;57(2):170\u20137.","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"3649_CR31","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/humrep\/del127","volume":"21","author":"T Ebner","year":"2006","unstructured":"Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-M\u00fcllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod (Oxford England). 2006;21(8):2022\u20136.","journal-title":"Hum Reprod (Oxford England)"},{"issue":"2","key":"3649_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3649_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/ajo.12183","volume":"54","author":"AW Shand","year":"2014","unstructured":"Shand AW, Whitton K, Pasfield A, Nassar N, McShane M, Han X, Henry A. Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2014;54(3):244\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"3649_CR34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/humrep\/deu033","volume":"29","author":"A Capalbo","year":"2014","unstructured":"Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, Nagy ZP, Ubaldi FM. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29(6):1173\u201381.","journal-title":"Hum Reprod"},{"issue":"6","key":"3649_CR35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0015-0282(99)00121-1","volume":"71","author":"K Pantos","year":"1999","unstructured":"Pantos K, Athanasiou V, Stefanidis K, Stavrou D, Vaxevanoglou T, Chronopoulou M. Influence of advanced age on the blastocyst development rate and pregnancy rate in assisted reproductive technology. Fertil Steril. 1999;71(6):1144\u20136.","journal-title":"Fertil Steril"},{"key":"3649_CR36","doi-asserted-by":"publisher","unstructured":"Glujovsky D, Farquhar C, Quinteiro Retamar AM, Alvarez Sedo CR, Blake D. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2016;(6):Cd002118. https:\/\/doi.org\/10.1002\/14651858.CD002118.pub5.","DOI":"10.1002\/14651858.CD002118.pub5"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03649-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T17:04:05Z","timestamp":1614963845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03649-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3649"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03649-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Shenzhen Maternity and Child Healthcare Hospital (SFYLS2019048). Given the retrospective nature of this study, the informed consent waived by the Medical Ethics Committee of Shenzhen Maternity and Child Healthcare Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}